Georgia Cancer Center at Augusta University, Augusta, Georgia
The Georgia Cancer Center in Augusta, Georgia is both a research institution and a clinical care site at which multidisciplinary teams of physicians offer high-quality medical treatments. Using a holistic approach to care, the facility provides access to world-class physicians, innovative treatments, and clinical trials,[1] including for patients diagnosed with lung cancer and malignant pleural mesothelioma.
The Georgia Cancer Center is part of Augusta University, Georgia’s health/sciences/medical college. Augusta is home to the Medical College of Georgia, the nation’s eighth-largest and 13th-oldest medical school. The cancer center conducts first-in-the-nation research in support of the National Cancer Institute’s goal of ensuring that every cancer patient has access to the newest and most innovative clinical trials in the nation. Through the care of local patients, it has made a significant impact on the global standard of cancer care.[2]
Pleural Mesothelioma and Lung Cancer Care at Georgia Cancer Center
The Georgia Cancer Center delivers compassionate care for patients diagnosed with malignant pleural mesothelioma and lung cancer patients, working to deliver a higher quality of life and the best possible outcomes. The medical team works to diagnose and stage patients’ conditions quickly and precisely so that they can create the best treatment plan for the individual patient, relying on artificial intelligence to improve the accuracy of diagnosis. By using a multidisciplinary approach, the various physicians treating the patients can collaborate to create the most effective and efficient treatment, coordinating tests and procedures in a way that optimizes the delivery of care.[3]
Treatment options include minimally invasive surgical techniques and advanced treatment options including Proton therapy with pencil scanning beam capability, intensity-modulated radiation therapy (IMRT), four-dimensional radiation therapy, image-guided radiation therapy, stereotactic radiation therapy, and targeted therapies including new chemotherapy agents, antibodies, and gene therapy.[3]
